Brain metabolism is abnormal in the mdx model of Duchenne muscular dystrophy

Brain

Volumn 119, Issue 3, 1996, Pages 1039-1044

  Tracey, I ^a,b   Dunn, J F ^a   Radda, G K ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b RADCLIFFE INFIRMARY   (United Kingdom)

Author keywords

31P MRS; Brain; Duchenne muscular dystrophy; mdx; Retardation

Indexed keywords

CREATINE; CREATINE PHOSPHATE; PHOSPHATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN; BRAIN METABOLISM; CELL VOLUME; CONTROLLED STUDY; DUCHENNE MUSCULAR DYSTROPHY; ENZYME ANALYSIS; METABOLITE; MOUSE; MOUSE MUTANT; NONHUMAN; PH; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL;

ANIMALS; BRAIN; CELL SIZE; DISEASE MODELS, ANIMAL; ENZYMES; MAGNETIC RESONANCE IMAGING; MICE; MICE, INBRED C57BL; MICE, INBRED MDX; MUSCULAR DYSTROPHIES; MUSCULAR DYSTROPHY, ANIMAL; PHOSPHORUS ISOTOPES;

EID: 0029975308     PISSN: 00068950     EISSN: None     Source Type: Journal    
DOI: 10.1093/brain/119.3.1039     Document Type: Article

References (42)

1. 31P MR spectroscopy in 28 patients with mitochondrial cytopathies. J Cereb Blood Flow Metab 1993; 13: 469-74.
2. Bergmeyer HU. Methods of enzymatic analysis. New York: Academic Press, 1974.
3. Bottomley PA, Drayer BP, Smith LS. Chronic adult cerebral infarction studied by phosphorus NMR spectroscopy. Radiology 1986; 160: 763-6.
4. Bulfield G, Siller WG, Wight PAL, Moore KJ. X chromosomelinked muscular dstrophy (mdx) in the mouse. Proc Natl Acad Sci USA 1984; 81: 1189-92.
5. 1H NMR detection of cerebral myo-inositol. FEBS Lett 1985; 187: 167-72.
6. Chamberlain JS, Pearlman JA, Muzny DM, Gibbs RA, Ranier JE, Caskey CT, et al. Expression of the murine Duchenne muscular dystrophy gene in muscle and brain. Science 1988; 239: 1416-18.
7. Chelly J, Hamard G, Koulakoff A, Kaplan JC, Kahn A, Berwald-Netter Y. Dystrophin gene transcribed from different promoters in neuronal and glial cells. Nature 1990; 344: 64-5.
8. Conn RB Jr. Fluorimetric determination of creatine. Clin Chem 1960; 6: 537-48.
9. Dubowitz V, Crome L. The central nervous system in Duchenne muscular dystrophy. Brain 1969; 92: 805-8.
10. Dunn JF, Frostick S, Brown G, Radda GK. Energy status of cells lacking dystrophin: an in vivo/in vitro study of mdx mouse skeletal muscle. Biochi Biophys Acta 1991; 1096: 115-20.
11. 31P-nuclear magnetic resonance study of mdx mice. Proc R Soc (Lond) B Biol Sci 1993a; 251: 201-6.
12. Dunn JF, Bannister N, Kemp GJ, Publicover SJ. Sodium is elevated in mdx muscles: ionic interactions in dystrophic cells. J Neurol Sci 1993b; 114: 76-80.
13. Emery AEH. Duchenne muscular dystrophy. Rev. ed. Oxford: Oxford University Press, 1988.
14. Ernst RR, Anderson WA. Application of Fourier transform spectroscopy to magnetic resonance. Rev Scient Instrum 1966; 37: 93-102.
15. Fenstermacher JD, Rail DP, Patlak CS, Levin VA. Ventriculocisternal perfusion as a technique for analysis of brain capillary permeability and extracellular transport. In: Crone C, Lassen NA, editors. Capillary permeability. Copenhagen: Munksgaard, 1970: 483-90.
16. 31P-NMR. In: Nuccitelli R, Deamer DW, editors. Intracellular pH: its measurement, regulation and utilization in cellular functions. New York: Alan R. Liss, 1982: 61-77.
17. Hayasaka K, Brown GK, Danks DM, Droste M, Kadenbach B. Cytochrome c oxidase deficiency in subacute necrotizing encephalopathy (Leigh syndrome). J Inherit Metab Dis 1989; 12: 247-56.
18. 31P magnetic resonance and biochemical investigation. J Neurol Sci 1985; 71: 105-18.
19. Hodgson SV, Abbs S, Clark S, Manzur A, Heckmatt JZ, Dubowitz V, et al. Correlation of clinical and deletion data in Duchenne and Becker muscular dystrophy, with special reference to mental ability. Neuromuscul Disord 1992; 2: 269-76.
20. Hoffman EP, Brown RH Jr, Kunkel LM. Dystrophin: the protein product of the Duchenne muscular dystrophy locus. Cell 1987; 51: 919-28.
21. Hoffman EP, Hudecki MS, Rosenberg PA, Pollina CM, Kunkel LM. Cell and fibre-type distribution of dystrophin. Neuron 1988; 1: 411-420.
22. Hope PL, Costello AM, Cady EB, Delpy DT, Tofts PS, Chu A, et al. Cerebral energy metabolism studied with phosphorus NMR spectroscopy in normal and birth-asphyxiated infants. Lancet 1984; 2: 366-70.
23. Hovstad L, Lochen EA, Sjaastad O. Pneumoencephalographic findings in various primary and secondary muscular disorders. Acta Neurol Scand 1976; 53: 128-36.
24. Karagan NJ. Intellectual functioning in Duchenne muscular dystrophy: a review. [Review]. Psychol Bull 1979; 86: 250-9.
25. Kemp GJ, Taylor DJ, Dunn JF, Frostick SP, Radda GK. Cellular energetics of dystrophic muscle. J Neurol Sci 1993; 116: 201-6.
26. Monaco AP, Neve RL, Colletti-Feener C, Bertelson CJ, Kurnit DM, Kunkel LM. Isolation of candidate cDNAs for portions of the Duchenne muscular dystrophy gene. Nature 1986; 323: 646-50.
27. Muntoni F, Mateddu A, Serra G. Passive avoidance behaviour deficit in the mdx mouse. Neuromuscul Disord 1991; 1: 121-3.
28. Newman RJ, Bore PJ, Chan L, Gadian DG, Styles P, Taylor D, et al. Nuclear magnetic resonance studies of forearm muscle in Duchenne dystrophy. Br Med J 1982; 284: 1072-4.
29. Nudel U, Robzyk K, Yaffe D. Expression of the putative Duchenne muscular dystrophy gene in differentiated myogenic cell cultures and in the brain. Nature 1988; 331: 635-8.
30. Nudel U, Zuk D, Einat P, Zeelon E, Levy Z, Neuman S, et al. Duchenne muscular dystrophy gene product is not identical in muscle and brain. Nature 1989; 337: 76-8.
31. Ponten U, Ratcheson RA, Salford LG, Siesjo BK. Optimal freezing conditions for cerebral metabolites in rats. J Neurochem 1973; 21: 1127-38.
32. Poole-Wilson PA, Cameron IR. ECS, intracellular pH, and electrolytes of cardiac and skeletal muscle. Am J Physiol 1975; 229: 1299-304.
33. Rapoport SI. Sites and functions of the blood-brain barrier. In: Blood-brain barrier in physiology and medicine. New York: Raven Press, 1976: 83-4.
34. Selzer ME, Myers RE, Holstein SB. Maturational changes in brain water and electrolytes in rhesus monkey with some implications for electrogenesis. Brain Res 1972; 45: 193-204.
35. Sheff MF, Zacks SI. Interstitial space of mouse skeletal muscle. J Physiol (Lond) 1982; 328: 507-19.
36. Toft PB, Leth H, Lou HC, Pryds O, Henriksen O. Metabolite concentrations in the developing brain estimated with proton MR spectroscopy. J Magn Reson Imaging, 1994; 4: 674-80.
37. 1H-Magnetic resonance spectroscopy study of mdx mouse brain: abnormal development of neural necrosis? J Neurol Sci 1966. In Press.
38. 31P-magnetic resonance spectroscopy and neuropsychological study. Lancet 1995; 345: 1260-4.
39. Veech RL, Lawson JW, Cornell NW, Krebs HA. Cytosolic phosphorylation potential. J Biol Chem 1979; 254: 6538-47.
40. Void RL, Waugh JS, Klein MP, Phelps DE. Measurement of spin relaxation in complex systems. J Chem Phys 1968; 48: 3831.
41. Wrogemann K, Pena SDJ. Mitochondrial calcium overload: a general mechanism for cell-necrosis in muscle diseases. Lancet 1976; 1: 672-4.
42. 31P NMR studies in Duchenne muscular dystrophy: age-related metabolic changes. Neurology 1987; 37: 165-9.